These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18320295)

  • 1. What is a suitable dissolution method for drug nanoparticles?
    Heng D; Cutler DJ; Chan HK; Yun J; Raper JA
    Pharm Res; 2008 Jul; 25(7):1696-701. PubMed ID: 18320295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability.
    Dhumal RS; Biradar SV; Yamamura S; Paradkar AR; York P
    Eur J Pharm Biopharm; 2008 Sep; 70(1):109-15. PubMed ID: 18502628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants.
    Zhang JY; Shen ZG; Zhong J; Hu TT; Chen JF; Ma ZQ; Yun J
    Int J Pharm; 2006 Oct; 323(1-2):153-60. PubMed ID: 16828244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology versus other techniques in improving drug dissolution.
    Kwok PC; Chan HK
    Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS; Biradar SV; Aher S; Paradkar AR
    J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid antisolvent preparation of amorphous cefuroxime axetil nanoparticles in a tube-in-tube microchannel reactor.
    Zhu WZ; Wang JX; Shao L; Zhang HX; Zhang QX; Chen JF
    Int J Pharm; 2010 Aug; 395(1-2):260-5. PubMed ID: 20493936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles.
    May S; Jensen B; Weiler C; Wolkenhauer M; Schneider M; Lehr CM
    Pharm Res; 2014 Nov; 31(11):3211-24. PubMed ID: 24852894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and characterization of cefuroxime axetil biphasic floating minitablets.
    Jammula S; Patra ChN; Swain S; Panigrahi KC; Nayak S; Dinda SC; Rao ME
    Drug Deliv; 2015 Jan; 22(1):125-35. PubMed ID: 24417642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and in vitro characterization of solid dosage form incorporating drug nanoparticles.
    Basa S; Muniyappan T; Karatgi P; Prabhu R; Pillai R
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1209-18. PubMed ID: 18720147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation.
    Patel VF; Patel NM
    AAPS PharmSciTech; 2006 Feb; 7(1):E17. PubMed ID: 16584147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions.
    Shah DA; Murdande SB; Dave RH
    J Pharm Sci; 2016 Jan; 105(1):10-24. PubMed ID: 26580860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocrystalization of Pioglitazone by Precipitation Method.
    Varshosaz J; Ahmadipour S; Tabbakhian M; Ahmadipour S
    Drug Res (Stuttg); 2018 Oct; 68(10):576-583. PubMed ID: 29631296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Amorphous Nanoparticles.
    Jog R; Burgess DJ
    J Pharm Sci; 2017 Jan; 106(1):39-65. PubMed ID: 27816266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theoretical-empirical analysis on the initial dissolution rate of drugs from polydispersed particles.
    Takano R; Takata N; Shiraki K; Higo S; Hayashi Y; Yamashita S
    Biol Pharm Bull; 2009 Nov; 32(11):1885-91. PubMed ID: 19881303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals.
    Murdande SB; Shah DA; Dave RH
    J Pharm Sci; 2015 Jun; 104(6):2094-2102. PubMed ID: 25821105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.